NCT04104945View on ClinicalTrials.gov

p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

October 21, 2028

Study Completion Date

October 21, 2028

Conditions
Squamous Cell Carcinoma of the Oropharynx
Interventions
RADIATION

De-intensified chemoradiotherapy

Radiotherapy to a dose of 60 Gy to the primary tumour and involved lymph nodes and 54 Gy to subclinical regions at risk in 30 fractions. Reduced volume of elective nodal radiation.

Trial Locations (1)

Unknown

RECRUITING

Tom Baker Cancer Centre, Calgary

All Listed Sponsors
collaborator

Tom Baker Cancer Centre

OTHER

collaborator

Cross Cancer Institute

OTHER

lead

AHS Cancer Control Alberta

OTHER